BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cytometry Part B: Clinical Cytometry Année : 2018

BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma

Résumé

Mutiple myeloma (MM) is a neoplasia characterized by the accumulation of malignant plasma cells (PC) in the bone marrow. Although proliferation markers have been studied in MM, none of the current staging systems include them. Moreover, approaches used to analyze proliferation do not separate MM cells (MMCs) from normal PC.
Fichier non déposé

Dates et versions

hal-02048196 , version 1 (25-02-2019)

Identifiants

Citer

Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, Laure Vincent, Anja Seckinger, et al.. BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma. Cytometry Part B: Clinical Cytometry, 2018, ⟨10.1002/cyto.b.21730⟩. ⟨hal-02048196⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More